Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors
- PMID: 26753914
- DOI: 10.1007/s12272-015-0703-7
Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors
Abstract
A series of pyridazin-3-one substituted with morpholino-pyrimidine derivatives was synthesized and evaluated as tyrosine kinase inhibitors against c-Met enzyme, and anti-proliferative activities of Hs746T human gastric cancer cell line. Most of compounds exhibited good biological activity, while compound 10, 12a, 14a displayed excellent c-Met enzyme inhibitory activities and Hs746T cell-based activities.
Keywords: Kinase inhibitor; Mesenchymal epithelial transition factor; Pyridazine derivatives; c-MET inhibitor.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous